Vanguard Group Inc. Decreases Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Vanguard Group Inc. trimmed its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 0.3% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 25,187,041 shares of the medical instruments supplier’s stock after selling 63,402 shares during the quarter. Vanguard Group Inc. owned 0.12% of DENTSPLY SIRONA worth $896,407,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. VisionPoint Advisory Group LLC grew its position in DENTSPLY SIRONA by 104.2% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after acquiring an additional 395 shares during the last quarter. Principal Securities Inc. purchased a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at approximately $26,000. Headlands Technologies LLC purchased a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at approximately $30,000. Parkside Financial Bank & Trust lifted its stake in shares of DENTSPLY SIRONA by 33.3% in the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after purchasing an additional 292 shares during the period. Finally, Anchor Investment Management LLC purchased a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at approximately $47,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on XRAY. Robert W. Baird lowered their price objective on DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a research note on Friday, May 3rd. Needham & Company LLC cut their price objective on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating for the company in a report on Friday, May 3rd. SVB Leerink initiated coverage on DENTSPLY SIRONA in a report on Monday, February 26th. They set an “outperform” rating and a $42.00 price target for the company. Evercore ISI cut their price target on DENTSPLY SIRONA from $40.00 to $35.00 and set an “outperform” rating for the company in a report on Friday, May 3rd. Finally, The Goldman Sachs Group cut their price target on DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating for the company in a report on Monday, May 6th. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, DENTSPLY SIRONA has a consensus rating of “Moderate Buy” and an average target price of $35.22.

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 3,577 shares of the firm’s stock in a transaction that occurred on Friday, May 31st. The stock was purchased at an average cost of $27.95 per share, with a total value of $99,977.15. Following the purchase, the director now owns 58,374 shares of the company’s stock, valued at $1,631,553.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.52% of the stock is owned by corporate insiders.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $25.45 on Friday. The stock has a 50 day moving average of $28.26 and a 200 day moving average of $31.96. DENTSPLY SIRONA Inc. has a 12 month low of $25.25 and a 12 month high of $41.65. The firm has a market cap of $5.28 billion, a PE ratio of -57.84, a PEG ratio of 1.14 and a beta of 1.04. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.42. The business had revenue of $953.00 million during the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The company’s revenue for the quarter was down 2.6% on a year-over-year basis. During the same period last year, the company earned $0.39 EPS. On average, research analysts expect that DENTSPLY SIRONA Inc. will post 2.03 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 12th. Investors of record on Friday, June 28th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.51%. The ex-dividend date is Friday, June 28th. DENTSPLY SIRONA’s dividend payout ratio is currently -145.45%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.